Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (NASDAQ:TPIV)

2.62
Delayed Data
As of Nov 21
 -0.03 / -1.13%
Today’s Change
2.61
Today|||52-Week Range
5.35
-32.47%
Year-to-Date
SECTOR
Consumer Services
INDUSTRY
Other Consumer Services
MARKET CAP
$27.6M

Company Description

TapImmune, Inc. is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Jacksonville, FL.

Contact Information

TapImmune, Inc.
50 North Laura Street
Jacksonville Florida 32202
P:(866) 359-7541
Investor Relations:

Employees

Shareholders

Individual stakeholders4.49%
Other institutional26.20%
Mutual fund holders0.98%

Top Executives

Peter L. HoangPresident, Chief Executive Officer & Director
Michael J. LoiaconoChief Financial Officer, Secretary & Treasurer
Elizabeth DonnellyDirector-Administration